持续性人乳头瘤病毒感染与宫颈癌的研究进展

被引:40
作者
周莉
陈姗
张帝开
机构
[1] 中山大学附属第六医院妇产科
关键词
乳头状瘤病毒,人; 宫颈肿廇; 持续感染; 病毒整合; 病毒载量; 免疫逃逸;
D O I
暂无
中图分类号
R737.33 [子宫肿瘤];
学科分类号
100214 ;
摘要
Human papillomavirus(HPV) genital infection is a very common sexual transmitted disease.Mostly,the infection is transient and asymptomatic.The induction of effective immune responses usually allows the infection to be spontaneously cured.However,the infection sometimes can be responsible for an intraepithelial lesion,which may progress to be cervical cancer.Cervical cancer is one of the most common neoplastic diseases affecting women.It is clear that carcinogenic HPV infection is the necessary process for the development of cervical cancer.HPV infection is very frequent in young women aged less than 25 years and viral clearance lasts for 8 months in average.This clearance is the consequence of host immunity intervention,which leads to spontaneous regression of infection and the overwhelming majority of low-grade squamous intraepithelial lesions(more than 80% within a period of 2 years).The major factor,which permits the progression to high grade squamous intraepithelial lesions and invasive cervical cancer,is the persistent feature of HPV infection.HPV infection is usually transient,but several factors were identified as host factors(genetic,immunodepression,oral contraception and smoking) and viral factors(genotype,variants,viral load and integration) to increase the persistence.Cervical cancer is clearly the first virus-induced solid tumor discovered in human.Furthermore,it represents a woman death cause that can be avoided.
引用
收藏
页码:2482 / 2486
页数:5
相关论文
共 5 条
[1]   高危型人乳头瘤病毒载量与子宫颈病变的关系 [J].
赵方辉 ;
胡尚英 ;
王少明 ;
陈凤 ;
张询 ;
章文华 ;
潘秦镜 ;
乔友林 .
中华预防医学杂志, 2009, (07)
[2]   人乳头状瘤病毒感染与子宫颈病变关系的研究进展及应对策略 [J].
王鲁平 .
诊断病理学杂志, 2007, (02) :86-89
[3]   高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究 [J].
钱德英 ;
岑坚敏 ;
王丁 ;
曾仁海 ;
林爱华 ;
舒焰红 ;
洪淡华 ;
黄志宏 .
中华妇产科杂志, 2006, (01) :34-37
[4]   Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine [J].
Nardelli-Haefliger, D ;
Lurati, F ;
Wirthner, D ;
Spertini, F ;
Schiller, JT ;
Lowy, DR ;
Ponci, F ;
De Grandi, P .
VACCINE, 2005, 23 (28) :3634-3641
[5]   Viral load of human papillomavirus and risk of CIN3 or cervical cancer [J].
Lorincz, AT ;
Castle, PE ;
Sherman, ME ;
Scott, DR ;
Glass, AG ;
Wacholder, S ;
Rush, BB ;
Gravitt, PE ;
Schussler, JE ;
Schiffman, M .
LANCET, 2002, 360 (9328) :228-229